Cardio Renal
Cardio Renal

Cardio Renal

DR15Ahrefs DR: 15/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent51Agent Readiness: 51/100. Top 25%. Measured by StartupHub.ai. Median 41.

French digital therapeutics company developing a non-invasive potassium monitoring device for CKD patients.

Website
2013InactiveParis, France

About

CardioRenal is a French company focused on improving the management of chronic kidney disease (CKD). They are developing TENOR, a digital therapeutics solution that includes a non-invasive medical device for patients to measure their blood potassium levels at home. This real-time data is then provided to physicians to help optimize treatment and prevent complications.

Key facts

At-a-glance profile data

Website
richardedmondson.net
Headquarters
Paris, France
Founded
2013
Total funding
$14M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Cardio Renal
DateRoundAmountLead investors
4 Apr 2022Seed$4M-
1 Jun 2021Seed$10MBpifrance
Add first review

Frequently asked

How much funding has Cardio Renal raised?

Cardio Renal has raised a total of $14M in funding. The most recent round on record is Seed.

What is Cardio Renal's current status?

Cardio Renal's current operating status is: Inactive.